EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Effectiveness and safety of consecutive single embryo transfer compared to double embryo transfer: results from the UK HFEA registry

Jack Tighe iD, Sophie Broughton, Rachel Roberts, Lorraine S Kasaven iD, Rachel Cutting, Elliot Bridges, Abigail Ng, Amanda Evans, Efstathios Theodorou, Jara Ben Nagi, Benjamin P Jones iD

Human Reproduction · 2025

DOI: 10.1093/humrep/deaf028 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Human Reproduction, 2025. Verfasst von Jack Tighe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK. Hauptthemen laut MEDLINE: Embryo Transfer, Single Embryo Transfer. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STUDY QUESTION How does two-consecutive single embryo transfer (2xSET) affect reproductive outcomes of IVF and ICSI compared to double embryo transfer (DET)? SUMMARY ANSWER Two-consecutive SET may provide greater or comparable live birth rate (LBR); with lower multiple birth, preterm birth, and pregnancy loss or neonatal death rates compared to DET. WHAT IS KNOWN ALREADY Elective SET in IVF/ICSI is widely encouraged over DET to minimize the risk of multiple births and associated morbidities. Despite this, multiple birth rates following IVF remain higher than the 10% target across Europe and the USA. Currently, the majority of evidence regarding SET and DET is based on various studies assessing outcomes such as LBR per treatment cycle, as opposed to per oocyte retrieval. As such, the representation of SET is mostly unfavourable. Analysis of cumulative LBR following the transfer of two embryos over consecutive cycles, rather than in one transfer event (DET) is more effective at distinguishing the two methods and will therefore provide more valuable information relevant to clinical practice. STUDY DESIGN, SIZE, DURATION This retrospective cohort study was conducted using Human Fertilisation and Embryology Authority (HFEA) register data, which encompasses national data from all IVF clinics in the UK. All women who underwent their first oocyte retrieval and IVF or ICSI treatment cycle with subsequent SET, DET, or 2xSET between 2010 and 2019 using blastocyst embryos were included (N = 71 807). PARTICIPANTS/MATERIALS, SETTING, METHODS The rate of live birth, liveborn baby rate, multiple birth, preterm birth, and pregnancy loss or neonatal death was compared between SET, DET, and 2xSET IVF/ICSI pregnancies using blastocyst-stage embryos, where data were stratified by maternal age. Data analysis was conducted in RStudio v4.2, alpha equals 0.05. MAIN RESULTS AND THE ROLE OF CHANCE Blastocyst-stage 2xSET achieved a greater median LBR of 0.47 (interquartile range [IQR] 0.13) than SET, 0.41 (IQR 0.13), and DET, 0.38 (IQR 0.13) (P < 0.05). Using SET as the reference standard, 2xSET was associated with a significantly lower odds of multiple births compared to DET ((odds ratio [OR] 6.87, 95% CI 6.14–7.68) vs 28.20, 95% CI 25.20–31.57). The odds of preterm birth were also lower following 2xSET (OR 1.11, 95% CI 1.06–1.15) compared to DET (OR 2.80, 95% CI 2.67–2.94). Similarly, the odds of pregnancy loss or neonatal death were lower following 2xSET (OR 1.14, 95% CI 1.08–1.21) compared to DET (OR 2.11, 95% CI 1.98–2.24). LBR was consistently higher following 2xSET than DET and SET in women aged 39 years and under (P < 0.05). However, results were comparable in women over 39 years (P > 0.05). Across all age groups, DET pregnancies had the highest multiple birth rate (P < 0.05). In women aged 39 years and under, DET was associated with the highest preterm birth rate (P < 0.05), whereas the rate was comparable across cohorts in women over 39 (P > 0.05). Moreover, pregnancy loss and neonatal death rates were highest following DET in women aged 37 years and under (P < 0.05), and comparable to SET and 2xSET in women over 37 years (P > 0.05). LIMITATIONS, REASONS FOR CAUTION Certain confounders are not recorded within HFEA registry data, including patient BMI, evaluation of embryo quality, and endometrial thickness at embryo transfer. Consequently, while our analysis identifies broad trends in embryo transfer success and morbidity, results may differ within certain patient populations. WIDER IMPLICATIONS OF THE FINDINGS Blastocyst-stage 2xSET may provide greater LBR in women aged 39 years and under, and comparable LBR in women over 39 years old, with overall lower multiple birth and morbidity than DET. 2xSET should be considered first-line among certain patient cohorts, including women with advanced maternal age to improve reproductive outcomes and reduce the risk of morbidity following ART. STUDY FUNDING/COMPETING INTEREST(S) No external funding was used for this study. None of the authors has any conflicts of interest. TRIAL REGISTRATION NUMBER This cohort study did not require registration. Following consultation with the Institutional Review Board at Imperial College London, ethical approval was not deemed necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embryo TransferSingle Embryo TransferHumansFemalePregnancyUnited KingdomRetrospective StudiesAdultRegistriesLive BirthFertilization in VitroPregnancy OutcomePregnancy RateSperm Injections, IntracytoplasmicInfant, NewbornPremature BirthBirth RatePregnancy, Multiple

Stichwörter der Autor:innen

birth rateembryo transferfertilization in vitrointracytoplasmic sperm injectionlive birthmultiplemultiple birthpregnancypreterm birthsingle embryo transfer

Autor:innen und Institutionen

  • Department of Gynaecology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Metabolism, Digestion and Reproduction, Institute of Reproductive & Developmental Biology, Imperial College London, Hammersmith Hospital Campus, London, UK.
  • School of Medicine, University of Birmingham, Birmingham, UK.
  • Centre for Reproductive and Genetic Health, London, UK.
  • Human Fertility and Embryology Authority (HFEA), London, UK.
  • The Lister Fertility Clinic, The Lister Hospital, London, UK.

ORCID-Profile: Jack Tighe, Lorraine S Kasaven, Benjamin P Jones

Zitieren

APA

Tighe, J., Broughton, S., Roberts, R., Kasaven, L. S., Cutting, R., Bridges, E., Ng, A., Evans, A., Theodorou, E., Ben Nagi, J., & Jones, B. P. (2025). Effectiveness and safety of consecutive single embryo transfer compared to double embryo transfer: results from the UK HFEA registry. Human Reproduction. https://doi.org/10.1093/humrep/deaf028

Vancouver

Tighe J, Broughton S, Roberts R, Kasaven LS, Cutting R, Bridges E, et al. Effectiveness and safety of consecutive single embryo transfer compared to double embryo transfer: results from the UK HFEA registry. Human Reproduction. 2025. doi:10.1093/humrep/deaf028

BibTeX
@article{Tighe2025,
  author = {Tighe, Jack and Broughton, Sophie and Roberts, Rachel and Kasaven, Lorraine S and Cutting, Rachel and Bridges, Elliot and Ng, Abigail and Evans, Amanda and Theodorou, Efstathios and Ben Nagi, Jara and Jones, Benjamin P},
  title = {Effectiveness and safety of consecutive single embryo transfer compared to double embryo transfer: results from the UK HFEA registry},
  journal = {Human Reproduction},
  year = {2025},
  doi = {10.1093/humrep/deaf028}
}
Kostenlos starten →